ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABBV AbbVie Inc

160.80
-0.92 (-0.57%)
After Hours
Last Updated: 22:36:24
Delayed by 15 minutes
Share Name Share Symbol Market Type
AbbVie Inc NYSE:ABBV NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.92 -0.57% 160.80 162.44 158.12 162.31 5,936,864 22:36:24

AbbVie Declares Quarterly Dividend

16/02/2023 5:41pm

PR Newswire (US)


AbbVie (NYSE:ABBV)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more AbbVie Charts.

NORTH CHICAGO, Ill., Feb. 16, 2023 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.48 per share. 

The cash dividend is payable May 15, 2023, to stockholders of record at the close of business on April 14, 2023.

Since the company's inception in 2013, AbbVie has increased its dividend by more than 270 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and gastroenterology, in addition to products and services across our Allergan Aesthetics portfolio. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

 

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-301749164.html

SOURCE AbbVie

Copyright 2023 PR Newswire

1 Year AbbVie Chart

1 Year AbbVie Chart

1 Month AbbVie Chart

1 Month AbbVie Chart

Your Recent History

Delayed Upgrade Clock